Enterohemorrhagic and other Shigatoxin-producing Escherichia coli - Escherichia coli: Pathotypes and Principles of Pathogenesis - page 162

Loirat, C., Fremeaux-Bacchi, V., 2011. Atypical hemolytic uremic syndrome. Orphanet J. Rare Dis.
6, 60 .
Loos, S., Ahlenstiel, T., Kranz, B., et al., 2012. An outbreak of shiga toxin-producing Escherichia coli
O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in
children. Clin. Infect. Dis. 55 (6), 753-759 .
Lopez, E.L., Contrini, M.M., Devoto, S., et al., 1995. Incomplete hemolytic-uremic syndrome in
Argentinean children with bloody diarrhea. J. Pediatr. 127 (3), 364-367 .
Lopez, E.L., Contrini, M.M., De Rosa, M.F., 1998. Epidemiology of shiga toxin producing
Escherichia coli in South America. Escherichia coli O157:H7 and other shiga toxin-producing
E. coli strains. In: Kaper, J.B., O'Brien, A.D. (Eds.), American Society for Microbiology,
Washington, D.C .
Low, A.S., Dziva, F., Torres, A.G., et al., 2006. Cloning, expression, and characterization of
imbrial operon F9 from enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 74
(4), 2233-2244 .
Luo, Y., Frey, E.A., Pfuetzner, R.A., et al., 2000. Crystal structure of enteropathogenic Escherichia
coli intimin-receptor complex. Nature 405 (6790), 1073-1077 .
Ma, C., Wickham, M.E., Guttman, J.A., et al., 2006. Citrobacter rodentium infection causes both
mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mito-
chondrial associated protein (Map). Cell Microbiol. 8 (10), 1669-1686 .
Majoul, I., Ferrari, D., Soling, H.D., 1997. Reduction of protein disulide bonds in an oxidizing
environment. The disulide bridge of cholera toxin A-subunit is reduced in the endoplasmic
reticulum. FEBS Lett. 401 (2-3), 104-108 .
Mallick, E.M., Brady, M.J., Luperchio, S.A., et al., 2012a. Allele- and Tir-independent functions of
intimin in diverse animal infection models. Front Microbiol. 3, 11 .
Mallick, E.M., McBee, M.E., Vanguri, V.K., et al., 2012b. A novel murine infection model for Shiga
toxin-producing Escherichia coli . J. Clin. Invest. 122 (11), In press .
Malyukova, I., Murray, K.F., Zhu, C., et al., 2009. Macropinocytosis in Shiga toxin 1 uptake by
human intestinal epithelial cells and transcellular transcytosis. Am. J. Physiol. Gastrointest.
Liver Physiol. 296 (1), G78-92 .
Manning, S.D., Motiwala, A.S., Springman, A.C., et al., 2008. Variation in virulence among clades
of Escherichia coli O157:H7 associated with disease outbreaks. Proc. Natl. Acad. Sci. USA
105 (12), 4868-4873 .
Marches, O., Covarelli, V., Dahan, S., et al., 2008. EspJ of enteropathogenic and enterohaemor-
rhagic Escherichia coli inhibits opsono-phagocytosis. Cell Microbiol. 10 (5), 1104-1115 .
Marches, O., Ledger, T.N., Boury, M., et al., 2003. Enteropathogenic and enterohaemorrhagic
Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition.
Mol. Microbiol. 50 (5), 1553-1567 .
Marches, O., Nougayrede, J.P., Boullier, S., et al., 2000. Role of tir and intimin in the viru-
lence of rabbit enteropathogenic Escherichia coli serotype O103:H2. Infect. Immun. 68 (4),
2171-2182 .
Martinez-Argudo, I., Sands, C., Jepson, M.A, 2007. Translocation of enteropathogenic Escherichia
coli across an in vitro M cell model is regulated by its type III secretion system. Cell Microbiol.
9 (6), 1538-1546 .
Matsuzawa, T., Kuwae, A., Abe, A., 2005. Enteropathogenic Escherichia coli type III effec-
tors EspG and EspG2 alter epithelial paracellular permeability. Infect. Immun. 73 (10),
6283-6289 .
McDaniel, T.K., Jarvis, K.G., Donnenberg, M.S., et al., 1995. A genetic locus of enterocyte
effacement conserved among diverse enterobacterial pathogens. Proc. Natl. Acad. Sci. USA
92 (5), 1664-1668 .